Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) along with its wholly owned subsidiary, Salix Pharmaceuticals (“Salix”), together with Salix’s licensor Alfasigma SpA (collectively the “Salix Parties”), today announced that the Company has filed a lawsuit against Sandoz Inc.,
October 1, 2019
· 4 min read